Primary human monocyte differentiation regulated by Nigella sativa pressed oil

Lipids in Health and Disease

Volumn 10, Issue 1, 2011, Pages

  Mat, Mahaya C ^a   Mohamed, Azman S ^b   Hamid, Shahrul S ^b  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^b ADVANCED MEDICAL AND DENTAL INSTITUTE   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; NIGELLA SATIVA OIL; OXIDIZED LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG; VEGETABLE OIL; CARAWAY OIL; ITGAM PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL SIZE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPID STORAGE; MACROPHAGE; MONOCYTE; PRIMARY CELL; PROTEIN EXPRESSION; BLACK CUMIN; CELL CULTURE; CELL ENLARGEMENT; CYTOLOGY; DRUG EFFECT; LIPID METABOLISM; METABOLISM; PHYSIOLOGY; PRIMARY CELL CULTURE;

ANTIGENS, CD11B; CELL DIFFERENTIATION; CELL ENLARGEMENT; CELLS, CULTURED; HUMANS; LIPID METABOLISM; LIPOPROTEINS, LDL; MONOCYTES; NIGELLA SATIVA; PLANT OILS; PRIMARY CELL CULTURE;

EID: 81355138187     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-216     Document Type: Article

References (54)

1. Chin S, Jeyaindran S, Azhari R, Wan Azman W, Omar I, Robaayah Z, Sim K: Acute Coronary Syndrome (ACS) Registry-Leading the charge for National Cardiovascular Disease (NCVD) Database. Med J Malaysia 2008, 63(Supplemen C):29-36.
2. Zambahari R: Trends in cardiovascular disease and risk factors in Malaysia. International Congress Series 2004, 1262:446-449.
3. Dollery CM, Libby P: Atherosclerosis and proteinase activation. Cardiovasc Res 2006, 69(3):625-635.
4. Nagy L, Tontonoz P, Alvarez JGA, Chen H, Evans RM: Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPAR3. Cell 1998, 93(2):229-240.
5. Steinberg D: Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime. Nat Med 2002, 8:1211-1217.
6. Toshima S, Hasegawa A, Kurabayashi M, Itabe H, Takano T, Sugano J, Shimamura K, Kimura J, Michishita I, Suzuki T, et al: Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 2000, 20(10):2243-2247.
7. Krieger M: The other site of scavenger receptors. Pattern recognition and host defense. Curr Opin Lipidology 1997, 8:275-280.
8. Osterud B, Bjorklid E: Role of Monocytes in Atherogenesis. Physiol Rev 2008, 83:1069-1112.
9. Osterud B, Bjorklid E: Role of monocytes in atherogenesis. Physiol Rev 2003, 83(4):1069-1112.
10. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ: Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995, 91(9):2488-2496.
11. Brown MS, Goldstein JL: A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232(4746):34-47.
12. Chisolm GM, Hazen SL, Fox PL, Cathcart MK: The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms. J Biol Chem 1999, 274(37):25959-25962.
13. Steinberg D: Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation 1997, 95(4):1062-1071.
14. Witztum JL, Steinberg D: Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991, 88(6):1785-1792.
15. Pasini AF, Anselmi M, Garbin U, Franchi E, Stranieri C, Nava MC, Boccioletti V, Vassanelli C, Cominacini L: Enhanced Levels of Oxidized Low-Density Lipoprotein Prime Monocytes to Cytokine Overproduction via Upregulation of CD14 and Toll-Like Receptor 4 in Unstable Angina. Arterioscler Thromb Vasc Biol 2007, 27(9):1991-1997.
16. Fuhrman B, Shiner M, Volkova N, Aviram M: Cell-induced copper ionmediated low density lipoprotein oxidation increases during in vivo monocyte-to-macrophage differentiation. Free Radic Biol Med 2004, 37(2):259-271.
17. Anderson DC, Springer TA: Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu Rev Med 1987, 38:175-194.
18. Stoneman V, Braganza D, Figg N, Mercer J, Lang R, Goddard M, Bennett M: Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques. Circ Res 2007, 100(6):884-893.
19. Weber C, Erl W, Weber PC: Enhancement of monocyte adhesion to endothelial cells by oxidatively modified low-density lipoprotein is mediated by activation of CD11b. Biochem Biophys Res Commun 1995, 206(2):621-628.
20. Vuorelaa P, Leinonenb M, Saikkuc P, Tammelaa P, Rauhad JP, Wennberge T, Vuorela H: Natural products in the process of finding new drug candidates. Curr Med Chem 2004, 11(11):1375-1389.
21. Ali BH, Blunden G: Pharmacological and toxicological properties of Nigella sativa. Phytother Res 2003, 17(4):299-305.
22. Al-Ghamdi MARaMS: A review of the pharmaco-therapeutic effects of Nigella sativa. Pakistan Journal of Medical Research 2002, 41(2):77-83.
23. El Tahir KEH, Ashour MMS, Al-Harbi MM: The cardiovascular actions of the volatile oil of the black seed (Nigella sativa) in rats: elucidation of the mechanism of action. General Pharmacology: The Vascular System 1993, 24(5):1123-1131.
24. Gali-Muhtasib H, Roessner A, Schneider-Stock R: Thymoquinone: a promising anti-cancer drug from natural sources. Int J Biochem Cell Biol 2006, 38(8):1249-1253.
25. El-Bahai MN, Al-Hariri MT, Yar T, Bamosa AO: Cardiac inotropic and hypertrophic effects of Nigella sativa supplementation in rats. Int J Cardiol 2009, 131(3):e115-117.
26. Michelsen KS, Doherty TM, Shah PK, Arditi M: TLR signaling: an emerging bridge from innate immunity to atherogenesis. J Immunol 2004, 173(10):5901-5907.
27. Majdalawieh AF, Hmaidan R, Carr RI: Nigella sativa modulates splenocyte proliferation, Th1/Th2 cytokine profile, macrophage function and NK anti-tumor activity. Journal of Ethnopharmacology 2010, 131(2):268-275.
28. El-Mahmoudy A, Matsuyama H, Borgan MA, Shimizu Y, El-Sayed MG, Minamoto N, Takewaki T: Thymoquinone suppresses expression of inducible nitric oxide synthase in rat macrophages. International Immunopharmacology 2002, 2(11):1603-1611.
29. Fararh KM, Atoji Y, Shimizu Y, Shiina T, Nikami H, Takewaki T: Mechanisms of the hypoglycemic and immunopotentiating effects of Nigella sativa L. oil in streptozocin-induced diabetic hamsters. Res Vet Sci 2004, 77:123-129.
30. Al-Naqeep G, Ismail M, Al-Zubairi A: Fatty Acid Profile, alpha-tocopherol and total antioxidant activity of extracted form Nigella sativa seeds. Int J Pharmacol 2009, 5:244-250.
31. Liu Q, Shu X, Wang L, Sun A, Liu J, Cao X: Albaconol, a plant-derived small molecule, inhibits macrophage function by suppressing NF-kappaB activation and enhancing SOCS1 expression. Cell Mol Immunol 2008, 5(4):271-278.
32. Nakamura T, Kodama N, Arai Y, Kumamoto T, Higuchi Y, Chaichantipyuth C, Ishikawa T, Ueno K, Yano S: Inhibitory effect of oxycoumarins isolated from the Thai medicinal plant Clausena guillauminii on the inflammation mediators, iNOS, TNF-alpha, and COX-2 expression in mouse macrophage RAW 264.7. J Nat Med 2009, 63(1):21-27.
33. Loppnow H, Werdan K, Buerke M: Vascular cells contribute to atherosclerosis by cytokine-and innate-immunity-related inflammatory mechanisms. Innate Immun 2008, 14(2):63-87.
34. Wang L, Geng C, Jiang L, Gong D, Liu D, Yoshimura H, Zhong L: The antiatherosclerotic effect of olive leaf extract is related to suppressed inflammatory response in rabbits with experimental atherosclerosis. Eur J Nutr 2008, 47(5):235-243.
35. Bechara C, Chai H, Lin PH, Yao Q, Chen C: Growth related oncogene-alpha (GRO-alpha): roles in atherosclerosis, angiogenesis and other inflammatory conditions. Med Sci Monit 2007, 13(6):RA87-90.
36. Salem ML: Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol 2005, 5(13-14):1749-1770.
37. Randhawa MA, Al-Ghamdi MS: A review on the pharmacotherapeutic effects of Nigella sativa. Pakistan J Med Res 2002, 41(2):1-10.
38. Yui S, Sasaki T, Miyazaki A, Horiuchi S, Yamazaki M: Induction of murine macrophage growth by modified LDLs. Arterioscler Thromb 1993, 13(3):331-337.
39. Shen LH, Zhou L, Wang BY, Pu J, Hu LH, Chai DJ, Wang L, Zeng JZ, He B: Oxidized low-density lipoprotein induces differentiation of RAW264.7 murine macrophage cell line into dendritic-like cells. Atherosclerosis 2008, 199(2):257-264.
40. Kanter M, Coskun O, Budancamanak M: Hepatoprotective effects of Nigella sativa L and Urtica dioica L on lipid peroxidation, antioxidant enzyme systems and liver enzymes in carbon tetrachloride-treated rats. World J Gastroenterol 2005, 11(42):6684-6688.
41. Meral I, Yener Z, Kahraman T, Mert N: Effect of Nigella sativa on glucose concentration, lipid peroxidation, anti-oxidant defence system and liver damage in experimentally-induced diabetic rabbits. J Vet Med A Physiol Pathol Clin Med 2001, 48(10):593-599.
42. Jafri SH, Glass J, Sui R, Zhang S, Prince M, Kleiner-Hancock H: Thymoquinone and cisplatin as a therapeutic combination in lung cancer. J Exp Clin Cancer Res 2010, 29(1):87-95.
43. Khan N, Sultana S: Inhibition of two stage renal carcinogenesis, oxidative damage and hyperproliferative response by Nigella sativa. Eur J Cancer Prev 2005, 14(2):159-168.
44. Curfs DM, Ghesquiere SA, Vergouwe MN, van der Made I, Gijbels MJ, Greaves DR, Verbeek JS, Hofker MH, de Winther MP: Macrophage secretory phospholipase A2 group X enhances anti-inflammatory responses, promotes lipid accumulation, and contributes to aberrant lung pathology. J Biol Chem 2008, 283(31):21640-21648.
45. Steinberg D, Parthasarathy S, Thomas C, Khoo E, John C, Witztum JL: Beyond Cholesterol: Modification of Low-Density Lipoprotein That Increase Its Atherogenecity. New England Journal of Medicine 1989, 320(14):915-924.
46. Heinecke JW, Rosen H, Chait A: Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest 1984, 74(5):1890-1894.
47. Fuhrman B, Partoush A, Volkova N, Aviram M: Ox-LDL induces monocyteto-macrophage differentiation in vivo: Possible role for the macrophage colony stimulating factor receptor (M-CSF-R). Atherosclerosis 2008, 196(2):598-607.
48. Al-Naqeep G, Al-Zubairi AS, Ismail M, Amom ZH, Esa NM: Antiatherogenic Potential of Nigella sativa Seeds and Oil in Diet-Induced Hypercholesterolemia in Rabbits. eCAM , neq071.
49. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D: Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proceedings of the National Academy of Sciences of the United States of America 1984, 81(12):3883-3887.
50. Muller Koboid AC, Kakenberg CGM, Tervaet JWC: Monocyte activation in patients with Wegener's granulomatosis. Ann Rheum Dis 1999, 58:237-245.
51. Spittler A, Willheim M, Leutmezer F, Ohler R, Krugluger W, Reissner C, Lucas S, Brodowicz T, Roth E, Boltznitulescu G: Effects of 1alpha,25-dihydroxyvitamin D3 and cytokines on the expression of MHC antigens, complement receptors and other antigens on human blood monocytes and U937 cells: role in cell differentiation, activation and phagocytosis. Immunology 1997, 90(2):286-293.
52. Auwerx J, Staels B, Van Vaeck F, Ceuppens JL: Changes in IgG Fc receptor expression induced by phorbol 12-myristate 13-acetate treatment of THP-1 monocytic leukemia cells. Leuk Res 1992, 16(3):317-327.
53. Yui S, Sasaki T, Miyazaki A, Horiuchi S, Yamazaki M: Induction of murine macrophage growth by modified LDLs. Arterioscler Thromb Vasc Biol 1993, 13(3):331-337.
54. Salma Cheikh-Rouhou SB, Hentati Basma, Blecker Christophe, Deroanne Claude, Hamadi Attia Nigella sativa L: Chemical composition and physicochemical characteristics of lipid fraction. Food Chemistry 2007, 101(2):673-681.